Baseline Performance and Fitting Parameters for Sonova Products
Launched by ADVANCED BIONICS · May 5, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study uses a prospective within-subjects repeated-measures design in which each subject serves as her/his own control. The purpose of this study is to assess the effectiveness and optimization of various FDA approved hardware, signal preprocessing and processing software, fitting characteristics, and service delivery methods, such as remote support and/or tele-audiology on an expanded subject demographic. The insights gained from this study will be used to optimize listening configuration recommendations, refine audiological practice, and inform future innovations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide Informed Consent/Assent
- • Adults (age +18 years) and children (8-17 years) can be enrolled in this study
- • If child is aged 8-17 years, an assent will be completed, and the subject must be accompanied by a parent or legal guardian for all study activities
- • Have the functional capability to operate the controls for the device and to comply with all directions during the study as determined by the investigator conducting the consent/baseline visit
- • English language proficiency as determined by the investigator
- Exclusion Criteria:
- • • Have any significant medical condition that, in the opinion of any of the investigators, is likely to interfere with study procedures or likely to confound evaluation of study endpoints
About Advanced Bionics
Advanced Bionics is a global leader in the development of innovative cochlear implant technology and hearing solutions. Committed to improving the quality of life for individuals with hearing loss, the company combines cutting-edge research with advanced engineering to create devices that enhance auditory experiences. Advanced Bionics actively sponsors clinical trials to evaluate the safety and efficacy of its products, ensuring they meet the highest standards of performance and patient satisfaction. With a focus on collaboration and innovation, the company strives to advance the field of auditory technology and provide transformative solutions for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported